http://rdf.ncbi.nlm.nih.gov/pubchem/measuregroup/AID1647654_PMID31975579

Outgoing Links

Predicate Object
has specified output http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442051213_AID1647654_PMID31975579_VALUE5
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442060441_AID1647654_PMID31975579_VALUE8
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442050196_AID1647654_PMID31975579_VALUE4
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442051878_AID1647654_PMID31975579_VALUE6
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442055454_AID1647654_PMID31975579_VALUE7
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442050094_AID1647654_PMID31975579_VALUE3
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442049017_AID1647654_PMID31975579_VALUE2
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID442063537_AID1647654_PMID31975579_VALUE9
http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID104234145_AID1647654_PMID31975579_VALUE1
has participant http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08183
source http://rdf.ncbi.nlm.nih.gov/pubchem/source/ChEMBL
title Reversal of P-gp mediated multidrug resistance in human SW620/AD300 cells assessed as fold-resistance by measuring [IC50 for SW620/AD300 cells to doxorubicin IC50 for SW620 cells] at 2.5 uM after 48 hrs by MTT assay (Rvb = 38 No_unit)
type http://www.bioassayontology.org/bao#BAO_0000040

Incoming Links

Predicate Subject
participates in http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442063537
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442051213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID104234145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442050094
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442055454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442050196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442049017
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442051878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442060441
has measure group http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1647654

Total number of triples: 23.